Clinical Trials on Glabellar Crease

Total 10000 results

‹
1
2
...
71
72
73
74
75
76
77
...
199
200
›

Xinhong Wu, PhD

Completed

Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer

Breast Cancer Stage III

China
Seagen Inc.

Completed

A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer (HER2CLIMB)

HER2 Positive Breast Cancer

United States, Spain, Belgium, Germany, Israel, France, United Kingdom, Austria, Denmark, Italy, Australia, Canada, Czechia, Portugal, Switzerland
Novartis Pharmaceuticals

Completed

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Japan, Hong Kong, Singapore
Gangnam Severance Hospital

Completed

SURPASS Retrospective Study

Breast Cancer | Sentinel Lymph Node | Breast MRI | Neoadjuvant Systemic Therapy
Novartis Pharmaceuticals

Completed

Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy (Treat ER+ight)

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer

Canada
Aarhus University Hospital

Completed

Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer (DBT)

Invasive Breast Cancer | Margins of Excision | Mastectomy, Segmental

Denmark
Instituto de Investigación Hospital Universitario...

Completed

Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women (Mamanut)

Breast Neoplasm Female | Cancer, Breast | Nutrition Related Cancer | Habits, Diet

Spain
University of Wisconsin, Madison
Millennium Pharmaceuticals, Inc.

Completed

A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer

Post Menopausal, Hormone Receptor Positive Breast Cancer

United States
University of California, San Diego

Withdrawn

Prophylactic Treatment of Sleep/Fatigue Before and During Chemotherapy

Stage, Breast Cancer

United States
Biocad

Completed

A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Human Epithelial Receptor (HER)-2 Positive Breast Cancer

Ukraine, Russian Federation, Belarus, India
Burzynski Research Institute

Terminated

Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer

Stage IV Breast Cancer

United States
NantCell, Inc.

Completed

QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Metastatic Cancer | Breast Tumors

United States, France, Canada, United Kingdom, Spain, Australia, Germany, Ireland, Switzerland
Kaplan Medical Center
Tel Aviv University; Rabin Medical Center; Tel-Aviv Sourasky Medical Center; Sheba...

Unknown

Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery

Primary Operable Breast Cancer

Israel
Eli Lilly and Company

Completed

A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease

Breast Cancer | Breast Neoplasms | Cancer of the Breast

United States
Beijing Biotech

Recruiting

Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC

HER2-positive Breast Cancer | Triple-negative Breast Cancer | Breast Cancer (Advanced/Metastatic)

China
Tianjin Medical University Cancer Institute and...

Recruiting

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Evaluating the Efficacy of Trop-2 ADC Combination Therapy in Advanced Triple-Negative Breast Cancer

China
Wake Forest University Health Sciences
Merck Sharp & Dohme LLC; G1 Therapeutics, Inc.

Active, not recruiting

Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer (ToPCourT)

Metastatic Triple-Negative Breast Cancer

United States
National Cancer Institute (NCI)

Active, not recruiting

Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

Recurrent Breast Carcinoma | HER2/Neu Positive | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIC Breast Cancer AJCC v7

United States
Mayo Clinic
National Cancer Institute (NCI)

Suspended

Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Locally Advanced Breast Carcinoma | Resectable Breast Carcinoma

United States
McMaster University
Canadian Breast Cancer Foundation

Completed

Trial Comparing Radioactive Seed Localization to Standard Procedure for Non-palpable Breast Cancers

Breast Cancer Invasive Nos | Stage 0 Breast Carcinoma

Canada
University Medical Center Groningen

Not yet recruiting

Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.

Breast Cancer

Netherlands
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Novartis; Hoffmann-La Roche

Not yet recruiting

A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.

Breast Cancer
Fudan University

Not yet recruiting

Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients. (IFOCOS)

Breast Cancer
AstraZeneca

Not yet recruiting

BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy (BEYOND)

Breast Cancer

United Arab Emirates
Centre Henri Becquerel

Not yet recruiting

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer (GATHER)

Breast Cancer

France
Royal College of Surgeons, Ireland

Recruiting

Evaluating the De-Escalation of Surveillance for Patients Who Have Undergone Curative Treatment for Breast Cancer (De-Escalation)

Breast Cancer

Ireland
iOMEDICO AG
Berlin Chemie AG

Not yet recruiting

Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer (ELENI)

Breast Cancer

Germany
Akeso

Not yet recruiting

A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer

Breast Cancer

China
M.D. Anderson Cancer Center

Not yet recruiting

Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers

Breast Cancer

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Endoscopic Skin-Sparing vs. Conventional Mastectomy for Wound Complications in BC

Breast Cancer

China
Ruijin Hospital

Not yet recruiting

Verification of Range Accuracy and Correlation With Clinical Toxicity Using Offline PET/CT for Hypofractionated Proton Radiotherapy in Breast Cancer (OFFLINE-PET-PR)

Breast Cancer
Centro di Riferimento Oncologico - Aviano

Recruiting

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Breast Cancer

Italy
Peking University Cancer Hospital & Institute

Not yet recruiting

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

Breast Cancer
Royal College of Surgeons, Ireland

Recruiting

A Prospective Study of the Genomic Landscape of Central Nervous System Disease Secondary to Breast Cancer Utilising Cell-free DNA Derived From Cerebrospinal Fluid (CSF) (PRIMROSE)

Breast Cancer

Ireland
TransThera Sciences (Nanjing), Inc.

Recruiting

Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment

Breast Cancer

China
Ruijin Hospital

Recruiting

Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation (RADIANT)

Breast Cancer

China
Casa di Cura Dott. Pederzoli

Recruiting

Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients (INFLUENCE II)

Breast Cancer

Italy
Royal College of Surgeons, Ireland

Recruiting

Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study). (MOZART)

Breast Cancer

Ireland
Fudan University

Not yet recruiting

A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI

Breast Cancer

China
Fudan University

Not yet recruiting

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

Breast Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Breast Cancer

China
European Institute of Oncology

Recruiting

Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE) (COMBINE-01)

Breast Cancer

Italy
D'Or Institute for Research and Education

Not yet recruiting

Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment (IARA)

Breast Cancer

Brazil
The First Affiliated Hospital with Nanjing Medical...

Not yet recruiting

Comparison of Breast Sensory Recovery Between Conventional and Endoscopic Nipple-Sparing Mastectomy Combined With Prepectoral Implant Reconstruction

Breast Cancer
Atridia Pty Ltd.

Not yet recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects With HR-Positive/HER2-Negative Solid Tumor

Breast Cancer
Salwa Shawky Bakeet Ali

Not yet recruiting

Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer

Breast Cancer

Egypt
Peking University Cancer Hospital & Institute

Not yet recruiting

Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity

Breast Cancer
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Breast Cancer

United States
Cairo University

Not yet recruiting

Effect of Virtual Reality on Pain and Anxiety During Chemotherapy Session in Breast Cancer Patients

Breast Cancer

Egypt
Jewish General Hospital

Not yet recruiting

FMT in Triple Negative Breast Cancer Guided by ctDNA (FRIDA)

Breast Cancer

Canada

‹
1
2
...
71
72
73
74
75
76
77
...
199
200
›

Subscribe